SKVI Offers Long-term Protection Against Highly Contagious Viruses
Skinvisible’s (OTCQB: SKVI
) antiseptic hand sanitizer lotion, DermSafe®, incorporates the company’s proprietary Invisicare® drug delivery technology and is 99.9 percent effective against a list of deadly bacteria and viruses. An article discussing the company reads: “One application of DermSafe provides a four-hour protective barrier that binds to the skin and actively combats the spread of germs between people and hard surfaces. The active ingredient is four percent chlorhexidine gluconate (CHG), the same active ingredient found in soaps used in hospital operating rooms. DermSafe offers long-term protection and destroys both gram-negative and gram-positive bacteria and viruses (http://nnw.fm/8dJbP
). It has been tested and proven effective against a host of infectious germs, including Methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli (E. coli) and salmonella. Sales of DermSafe have already taken off in China, and the product will be marketed throughout the country.”
To view the full article, visit http://nnw.fm/ZGnU5
About Skinvisible Pharmaceuticals, Inc.
Skinvisible Pharmaceuticals is a research and development company that licenses its proprietary formulations made with Invisicare®, its patented polymer delivery system that offers life-cycle management and unique enhancements for topically delivered products. Invisicare holds active ingredients on the skin for extended periods of time, allowing for the controlled release of actives. For more information, visit the company’s website at www.Skinvisible.com